Testing Compounds for Antiviral Activity in Cell Cultures Infected with HIV

  • Donna Devine
  • Naomi Mathews
  • Derek Kinchington
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 24)


This chapter describes the procedures that can be used to determine compounds that have antiviral activity against HIV. These include: maintenance of lymphoblastoid cell lines, preparation of peripheral blood mononuclear cells (PMMCs), and determination of the infectivity of the HIV stock-supernatant and antiviral assays. The assays described use both acutely and chronically infected cells. Toxicity of compounds is assessed by measuring 14C uptake. These protocols are used for the evaluation of compounds that can be carried out by a single individual in a Category 3 containment laboratory. The number of compounds analyzed would be about 10, which is a convenient number to fill a single 96-well p24 enzyme-linked immunosorbent assay (ELISA) plate.


Antiviral Activity C8166 Cell Buffy Coat Virus Stock Uninfected Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Krohn, A., Lambert, R. W., Merrett, J. H., Mills, J. S., Parks, K. E. B., Redshaw, S., Ritchie, A. J., Taylor, D. L., Thomas, G. J., and Machin, P. (1990) Rational design of peptide-based HIV proteinase inhibitors. Science 248, 358–361.CrossRefPubMedGoogle Scholar
  2. 2.
    Holmes, H. C., Mahmoud, N., Karpas, A., Petric, J., Kinchington, D., O’Connor, T., Jeffries, D. J., De Clercq, E., Pauwels, R., Desmyter, J., and Hay, A. (1991) Screening of compounds for activity against HIV: a collaborative study. Antiviral Chem. Chemother. 2, 287–293.Google Scholar
  3. 3.
    Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter J., and De Clercq, E. (1988) Rapid and automated tetrazolium-basd colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20, 309–321.CrossRefPubMedGoogle Scholar
  4. 4.
    Dulbecco, R. (1994) Endpoint method—measurement of the infectious titer of a viral sample, in Virology, 2nd ed., Lippincott, Philadelphia, pp. 22–25.Google Scholar
  5. 5.
    Galpin, S., Roberts, N. A., O’ Connor, T., Jeffries, D. J., and Kinchington, D. (1993) Antiviral properties of the HIV proteinase inhibitor RO 31-8959. Antiviral Chem. Chemother. 5, 43–45.Google Scholar
  6. 6.
    Kinchington, D., Randall, S., Winther, M., and Horrobin, D. (1993) Lithium gamma-linolenate-induced cytotoxicity against cells chronically infected with HIV-1. FEBS Letts. 330, 219–221.CrossRefGoogle Scholar
  7. 7.
    Pauwels, R., Andries, K., Debyser, Z., Kukla, M., Schols, D., Desmyter, J., De Clercq, E., and Janssen, P. A. (1992) TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication. Biochem. Soc. Trans. 20(2), 509–512.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  • Donna Devine
  • Naomi Mathews
  • Derek Kinchington

There are no affiliations available

Personalised recommendations